[go: up one dir, main page]

GR1007725B - Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας - Google Patents

Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας

Info

Publication number
GR1007725B
GR1007725B GR20110100599A GR20110100599A GR1007725B GR 1007725 B GR1007725 B GR 1007725B GR 20110100599 A GR20110100599 A GR 20110100599A GR 20110100599 A GR20110100599 A GR 20110100599A GR 1007725 B GR1007725 B GR 1007725B
Authority
GR
Greece
Prior art keywords
preparation
highly pure
duloxetine hydrochloride
pure duloxetine
duloxetine
Prior art date
Application number
GR20110100599A
Other languages
English (en)
Inventor
Θεοχαρης Βασιλειου Κοφτης
Θεοδωρος Δημητριου Παναγιωτιδης
Θεοδωρος Αντωνιου Τσατσας
Αστερια Ιωαννη-Αστεριου Ζητρου
Original Assignee
Φαρματεν Αβεε,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Φαρματεν Αβεε, filed Critical Φαρματεν Αβεε,
Priority to GR20110100599A priority Critical patent/GR1007725B/el
Priority to CN201280051251.1A priority patent/CN103958494A/zh
Priority to IN1022KON2014 priority patent/IN2014KN01022A/en
Priority to PCT/EP2012/004312 priority patent/WO2013056809A1/en
Publication of GR1007725B publication Critical patent/GR1007725B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά βελτιωμένη μέθοδο παρασκευής Ντουλοξετίνης και φαρμακευτικά αποδεκτών αλάτων ή παραγώγων αυτής και συγκεκριμένα μια μέθοδο για μαζική παραγωγή υδροχλωρικής Ντουλοξετίνης με υψηλή απόδοση και υψηλή εναντιομερική και χημική καθαρότητα.
GR20110100599A 2011-10-17 2011-10-17 Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας GR1007725B (el)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GR20110100599A GR1007725B (el) 2011-10-17 2011-10-17 Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας
CN201280051251.1A CN103958494A (zh) 2011-10-17 2012-10-16 高纯度盐酸度洛西汀的制备方法
IN1022KON2014 IN2014KN01022A (el) 2011-10-17 2012-10-16
PCT/EP2012/004312 WO2013056809A1 (en) 2011-10-17 2012-10-16 Process for the preparation of highly pure duloxetine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20110100599A GR1007725B (el) 2011-10-17 2011-10-17 Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας

Publications (1)

Publication Number Publication Date
GR1007725B true GR1007725B (el) 2012-10-18

Family

ID=47071219

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20110100599A GR1007725B (el) 2011-10-17 2011-10-17 Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας

Country Status (4)

Country Link
CN (1) CN103958494A (el)
GR (1) GR1007725B (el)
IN (1) IN2014KN01022A (el)
WO (1) WO2013056809A1 (el)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2060559A1 (en) * 2007-11-19 2009-05-20 Cadila Pharmaceuticals Limited Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers
WO2010003942A2 (en) * 2008-07-07 2010-01-14 Krka, D.D. Novo Mesto Preparation of duloxetine and its pharmaceutically acceptable salts by the use of asymmetric transfer hydrogenation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007433A (ko) 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
US7538232B2 (en) 2006-01-19 2009-05-26 Eli Lilly And Company Process for the asymmetric synthesis of duloxetine
WO2009074883A2 (en) 2007-11-06 2009-06-18 Medichem, S.A. Improved process for preparing duloxetine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2060559A1 (en) * 2007-11-19 2009-05-20 Cadila Pharmaceuticals Limited Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers
WO2010003942A2 (en) * 2008-07-07 2010-01-14 Krka, D.D. Novo Mesto Preparation of duloxetine and its pharmaceutically acceptable salts by the use of asymmetric transfer hydrogenation process

Also Published As

Publication number Publication date
WO2013056809A1 (en) 2013-04-25
CN103958494A (zh) 2014-07-30
IN2014KN01022A (el) 2015-10-09

Similar Documents

Publication Publication Date Title
MX2015005286A (es) Procedimiento para la preparación de derivados del ácido biliar.
TN2013000411A1 (en) Branched 3-phenylpropionic acid derivatives and the use thereof
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
MX361183B (es) Derivados de 1,4-ciclohexilamina y procesos para la preparación de los mismos.
MY164371A (en) Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
MX360048B (es) Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico.
IN2014DN06964A (el)
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
MX2012001722A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
IN2014DN09451A (el)
MX2011012233A (es) Soluciones de retinoide topicas.
UA106208C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
WO2013046233A3 (en) Process for the preparation of octreotide acetate
GR1007725B (el) Μεθοδος δια την παρασκευη υδροχλωρικης ντουλοξετινης υψηλης καθαροτητας
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MY160928A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
PH12013500256A1 (en) Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives
MX366887B (es) Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación.
WO2014083572A8 (en) A process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof
IN2012DE00862A (el)
TN2013000054A1 (en) Process for the preparation of enantiomeric forms of 2,3 - diaminopropionic acid derivatives
TN2013000128A1 (en) Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20121122